CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, D. H.
Right arrow Articles by Babiss, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, D. H.
Right arrow Articles by Babiss, L. E.

Cell Growth & Differentiation, Vol 6, Issue 9 1053-1061, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Misregulated expression of the cyclin dependent kinase 2 protein in human fibroblasts is accompanied by the inability to maintain a G2 arrest following DNA damage

DH Walker, GR Adami, KM Dold and LE Babiss
Department of Molecular Cell Biology, Glaxo Research Institute, Research Triangle Park, North Carolina 27709, USA.

The misregulation of cell cycle checkpoints has been implicated in the onset of neoplasia. To thoroughly understand the differences in checkpoint regulation between normal and transformed cells, we have compared the cell cycle responses of normal and TAg-transformed fibroblasts to DNA damage by gamma-irradiation. Normal cell lines arrest in both G1 and G2 for in excess of 48 h after DNA damage. Surprisingly, both cyclin-dependent kinase 2 (CDK2) and cyclin A proteins were specifically down-regulated within 24 h of DNA damage. In contrast, TAg transformed cells did not down-regulate either cyclin A or CDK2 after DNA damage and showed a significantly shortened G2 arrest. To investigate the role CDK2 down-regulation plays in cell cycle arrests, we generated normal cell lines that constitutively overexpress CDK2. These cells fail to down-regulate both CDK2 protein and CDK2 protein kinase activity after DNA damage and also show a G2 checkpoint defect; although the cells are able to normally initiate both a G1 and a G2 arrest, they prematurely escape the G2-M arrest after DNA damage. The escape from G2 correlates with an illicit activation of cyclin B-associated protein kinase activity in these cells. These results suggest that the misregulation of CDK2 contributes to the failure of checkpoint control by allowing cells to enter mitosis prematurely.


This article has been cited by other articles:


Home page
J Biol ChemHome page
M. Roh, C. Song, J. Kim, and S. A. Abdulkadir
Chromosomal Instability Induced by Pim-1 Is Passage-dependent and Associated with Dysregulation of Cyclin B1
J. Biol. Chem., December 9, 2005; 280(49): 40568 - 40577.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Martinez, O. Vogler, J. Casas, F. Barcelo, R. Alemany, J. Prades, T. Nagy, C. Baamonde, P. G. Kasprzyk, S. Teres, et al.
Membrane Structure Modulation, Protein Kinase C{alpha} Activation, and Anticancer Activity of Minerval
Mol. Pharmacol., February 1, 2005; 67(2): 531 - 540.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X.-Y. Yin, L. Grove, N. S. Datta, K. Katula, M. W. Long, and E. V. Prochownik
Inverse Regulation of Cyclin B1 by c-Myc and p53 and Induction of Tetraploidy by Cyclin B1 Overexpression
Cancer Res., September 1, 2001; 61(17): 6487 - 6493.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. M. Flatt, L. J. Tang, C. D. Scatena, S. T. Szak, and J. A. Pietenpol
p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent
Mol. Cell. Biol., June 15, 2000; 20(12): 4210 - 4223.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
J.-L. Lenormand, R. W. Dellinger, K. E. Knudsen, S. Subramani, and D. J. Donoghue
Speedy: a novel cell cycle regulator of the G2/M transition
EMBO J., April 1, 1999; 18(7): 1869 - 1877.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.